Total Payments
$17,578
2024 Payments
$2,754
Companies
29
Transactions
126
Medicare Patients
544
Medicare Billing
$78,886
Payment Breakdown by Category
Consulting$9,931 (56.5%)
Education$2,500 (14.2%)
Food & Beverage$2,349 (13.4%)
Travel$2,049 (11.7%)
Other$750.00 (4.3%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $9,931 | 4 | 56.5% |
| Education | $2,500 | 1 | 14.2% |
| Food and Beverage | $2,349 | 113 | 13.4% |
| Travel and Lodging | $2,049 | 7 | 11.7% |
| Grant | $750.00 | 1 | 4.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ACADIA Pharmaceuticals Inc | $7,301 | 13 | $0 (2021) |
| Merck Sharp & Dohme LLC | $5,046 | 9 | $0 (2023) |
| INTUITIVE SURGICAL, INC. | $2,517 | 2 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $947.07 | 3 | $0 (2023) |
| Lilly USA, LLC | $186.07 | 11 | $0 (2018) |
| Avanir Pharmaceuticals, Inc. | $163.96 | 9 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $161.41 | 8 | $0 (2019) |
| Sunovion Pharmaceuticals Inc. | $158.87 | 7 | $0 (2020) |
| Allergan Inc. | $139.32 | 10 | $0 (2017) |
| Otsuka America Pharmaceutical, Inc. | $137.05 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,754 | 14 | INTUITIVE SURGICAL, INC. ($2,517) |
| 2023 | $2,047 | 17 | Merck Sharp & Dohme LLC ($1,740) |
| 2022 | $1,034 | 8 | SANOFI-AVENTIS U.S. LLC ($922.25) |
| 2021 | $174.55 | 10 | AstraZeneca Pharmaceuticals LP ($40.68) |
| 2020 | $126.55 | 8 | Biogen, Inc. ($31.60) |
| 2019 | $7,395 | 17 | ACADIA Pharmaceuticals Inc ($7,190) |
| 2018 | $321.41 | 18 | Lilly USA, LLC ($132.29) |
| 2017 | $3,726 | 34 | Merck Sharp & Dohme Corporation ($3,306) |
All Payment Transactions
126 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/22/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.78 | General |
| Category: PSYCHIATRY | ||||||
| 11/21/2024 | Almatica Pharma LLC | TERIPARATIDE (Drug), LOREEV XR | Food and Beverage | In-kind items and services | $17.47 | General |
| Category: OSTEOPOROSIS | ||||||
| 10/07/2024 | Almatica Pharma LLC | TERIPARATIDE (Drug), LOREEV XR | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: OSTEOPOROSIS | ||||||
| 09/09/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: PSYCHIATRY | ||||||
| 08/06/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.17 | General |
| Category: PSYCHIATRY | ||||||
| 06/12/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $26.30 | General |
| Category: ANTI-ANXIETY | ||||||
| 06/07/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $17.35 | General |
| Category: PSYCHIATRY | ||||||
| 05/01/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $17.72 | General |
| Category: Cardiology | ||||||
| 03/26/2024 | ABBVIE INC. | LINZESS (Drug) | Food and Beverage | In-kind items and services | $30.98 | General |
| Category: GASTROENTEROLOGY | ||||||
| 02/07/2024 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $15.37 | General |
| Category: NEUROLOGY | ||||||
| 01/24/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $19.99 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 01/18/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Education | In-kind items and services | $2,500.00 | General |
| Category: SURGERY | ||||||
| 01/18/2024 | INTUITIVE SURGICAL, INC. | Da Vinci Surgical System (Device) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: SURGERY | ||||||
| 01/11/2024 | Actelion Pharmaceuticals US, Inc. | OPSUMIT (Drug) | Food and Beverage | In-kind items and services | $20.29 | General |
| Category: Cardiology | ||||||
| 12/18/2023 | Merck Sharp & Dohme LLC | — | Consulting Fee | Cash or cash equivalent | $1,740.00 | General |
| 12/14/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $21.75 | General |
| Category: PSYCHIATRY | ||||||
| 11/20/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $16.51 | General |
| Category: PSYCHIATRY | ||||||
| 10/31/2023 | Neurelis, Inc. | VALTOCO (Drug) | Food and Beverage | In-kind items and services | $16.74 | General |
| Category: EPILEPSY | ||||||
| 10/24/2023 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $24.67 | General |
| Category: VACCINES | ||||||
| 09/27/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $20.98 | General |
| Category: PSYCHIATRY | ||||||
| 08/02/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/19/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $13.14 | General |
| Category: PSYCHIATRY | ||||||
| 06/27/2023 | Otsuka America Pharmaceutical, Inc. | NUEDEXTA (Drug) | Food and Beverage | In-kind items and services | $12.96 | General |
| Category: NEUROLOGY | ||||||
| 06/13/2023 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: PSYCHIATRY | ||||||
| 05/31/2023 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $22.12 | General |
| Category: PSYCHIATRY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 6 | 196 | 249 | $48,867 | $26,087 |
| 2022 | 5 | 109 | 311 | $24,505 | $17,067 |
| 2021 | 5 | 137 | 341 | $26,969 | $20,085 |
| 2020 | 5 | 102 | 255 | $20,490 | $15,647 |
Total Patients
544
Total Services
1,156
Medicare Billing
$78,886
Procedure Codes
21
All Medicare Procedures & Services
21 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99306 | Initial nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 97 | 103 | $30,690 | $15,261 | 49.7% |
| 99344 | Residence visit for new patient with moderate level of medical decision making, per day, if using time, at least 60 minutes | Office | 2023 | 24 | 24 | $4,752 | $2,826 | 59.5% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 17 | 40 | $3,235 | $2,448 | 75.7% |
| 99310 | Subsequent nursing facility care with high level of medical decision making, per day, if using time, at least 45 minutes | Facility | 2023 | 18 | 18 | $4,680 | $2,264 | 48.4% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 22 | 22 | $3,410 | $1,924 | 56.4% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Facility | 2023 | 18 | 42 | $2,100 | $1,365 | 65.0% |
| 99307 | Follow-up nursing facility visit per day, typically 10 minutes | Facility | 2022 | 29 | 177 | $8,850 | $5,918 | 66.9% |
| 99308 | Follow-up nursing facility visit per day, typically 15 minutes | Facility | 2022 | 28 | 78 | $6,240 | $4,224 | 67.7% |
| 99306 | Initial nursing facility visit per day, typically 45 minutes | Facility | 2022 | 19 | 21 | $3,780 | $2,863 | 75.8% |
| 99336 | Established patient custodial care facility, group care, or assisted living visit, typically 40 minutes | Office | 2022 | 22 | 24 | $3,453 | $2,376 | 68.8% |
| 99327 | New patient custodial care facility, group care, or assisted living visit, typically 1 hour | Office | 2022 | 11 | 11 | $2,182 | $1,685 | 77.2% |
| 99307 | Subsequent nursing facility visit, typically 10 minutes per day | Facility | 2021 | 38 | 217 | $10,850 | $7,889 | 72.7% |
| 99306 | Initial nursing facility visit, typically 45 minutes per day | Facility | 2021 | 26 | 27 | $4,860 | $3,770 | 77.6% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2021 | 33 | 55 | $4,400 | $3,200 | 72.7% |
| 99336 | Established patient assisted living visit, typically 40 minutes | Office | 2021 | 25 | 27 | $3,884 | $2,892 | 74.4% |
| 99327 | New patient assisted living visit, typically 60 minutes | Office | 2021 | 15 | 15 | $2,975 | $2,334 | 78.4% |
| 99307 | Subsequent nursing facility visit, typically 10 minutes per day | Facility | 2020 | 27 | 148 | $7,400 | $5,542 | 74.9% |
| 99306 | Initial nursing facility visit, typically 45 minutes per day | Facility | 2020 | 29 | 37 | $6,660 | $5,217 | 78.3% |
| 99308 | Subsequent nursing facility visit, typically 15 minutes per day | Facility | 2020 | 21 | 41 | $3,280 | $2,405 | 73.3% |
| 99336 | Established patient assisted living visit, typically 40 minutes | Office | 2020 | 11 | 13 | $1,870 | $1,492 | 79.8% |
| 99315 | Nursing facility discharge day management, 30 minutes or less | Facility | 2020 | 14 | 16 | $1,280 | $991.76 | 77.5% |
About Dr. Daniel Haimowitz, MD
Dr. Daniel Haimowitz, MD is a Geriatric Medicine healthcare provider based in Levittown, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/05/2007. The National Provider Identifier (NPI) number assigned to this provider is 1013064377.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Daniel Haimowitz, MD has received a total of $17,578 in payments from pharmaceutical and medical device companies, with $2,754 received in 2024. These payments were reported across 126 transactions from 29 companies. The most common payment nature is "Consulting Fee" ($9,931).
As a Medicare-enrolled provider, Haimowitz has provided services to 544 Medicare beneficiaries, totaling 1,156 services with total Medicare billing of $78,886. Data is available for 4 years (2020–2023), covering 21 distinct procedure/service records.
Ad
Practice Information
- Specialty Geriatric Medicine
- Other Specialties Internal Medicine
- Location Levittown, PA
- Active Since 01/05/2007
- Last Updated 12/22/2010
- Taxonomy Code 207RG0300X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1013064377
Products in Payments
- NUPLAZID (Drug) $7,301
- Da Vinci Surgical System (Device) $2,517
- REXULTI (Drug) $183.20
- NUEDEXTA (Drug) $161.66
- TRULICITY (Drug) $145.71
- NAMZARIC (Drug) $139.32
- ENTRESTO (Drug) $116.53
- XARELTO (Drug) $92.36
- LONHALA MAGNAIR (Drug) $80.90
- INVOKANA (Drug) $69.05
- AUSTEDO (Drug) $58.65
- Nuedexta (Drug) $51.49
- ADLARITY (Drug) $45.78
- LOKELMA (Drug) $40.68
- OPSUMIT (Drug) $38.01
- TERIPARATIDE (Drug) $36.13
- FARXIGA (Drug) $36.10
- BUTRANS (Drug) $34.02
- LINZESS (Drug) $30.98
- TRADJENTA (Drug) $29.46
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.